INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 1,221,125 Value ($000) $4,885 Avg Close Range
Q1 2025
Shares 1,230,765 Value ($000) $1,120 Avg Close Range
Q4 2024
Shares 1,179,622 Value ($000) $3,268 Avg Close Range
Q3 2024
Shares 1,171,172 Value ($000) $6,126 Avg Close Range
Q2 2024
Shares 1,151,673 Value ($000) $5,137 Avg Close Range
Q1 2024
Shares 1,067,479 Value ($000) $8,178 Avg Close Range
Q4 2023
Shares 1,032,716 Value ($000) $4,400 Avg Close Range
Q3 2023
Shares 822,823 Value ($000) $3,456 Avg Close Range
Q2 2023
Shares 617,459 Value ($000) $3,439 Avg Close Range
Q1 2023
Shares 241,208 Value ($000) $1,382 Avg Close Range
Q4 2022
Shares 233,126 Value ($000) $0 Avg Close Range
Q3 2022
Shares 233,685 Value ($000) $626 Avg Close Range
Q2 2022
Shares 216,925 Value ($000) $1,034 Avg Close Range
Q1 2022
Shares 186,007 Value ($000) $760 Avg Close Range
Q4 2021
Shares 184,019 Value ($000) $1,255 Avg Close Range
Q3 2021
Shares 198,624 Value ($000) $2,302 Avg Close Range
Q2 2021
Shares 179,672 Value ($000) $3,061 Avg Close Range
Q1 2021
Shares 150,361 Value ($000) $2,977 Avg Close Range
Q4 2020
Shares 106,446 Value ($000) $2,197 Avg Close Range
Q3 2020
Shares 98,284 Value ($000) $2,583 Avg Close Range